829 related articles for article (PubMed ID: 31391546)
1. Modeling Alzheimer's disease with iPSC-derived brain cells.
Penney J; Ralvenius WT; Tsai LH
Mol Psychiatry; 2020 Jan; 25(1):148-167. PubMed ID: 31391546
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's Disease: Insights from Genetic Mouse Models and Current Advances in Human IPSC-Derived Neurons.
Harasta AE; Ittner LM
Adv Neurobiol; 2017; 15():3-29. PubMed ID: 28674976
[TBL] [Abstract][Full Text] [Related]
3. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
4. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
Machairaki V
Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
[TBL] [Abstract][Full Text] [Related]
5. Stem Cell Therapies in Alzheimer's Disease: Applications for Disease Modeling.
Si Z; Wang X
J Pharmacol Exp Ther; 2021 May; 377(2):207-217. PubMed ID: 33558427
[TBL] [Abstract][Full Text] [Related]
6. IPSC-Derived Neuronal Cultures Carrying the Alzheimer's Disease Associated
Martins S; Müller-Schiffmann A; Erichsen L; Bohndorf M; Wruck W; Sleegers K; Van Broeckhoven C; Korth C; Adjaye J
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630447
[TBL] [Abstract][Full Text] [Related]
7. Precision Modulation of Neurodegenerative Disease-Related Gene Expression in Human iPSC-Derived Neurons.
Heman-Ackah SM; Bassett AR; Wood MJ
Sci Rep; 2016 Jun; 6():28420. PubMed ID: 27341390
[TBL] [Abstract][Full Text] [Related]
8. Modeling Alzheimer's disease with human iPS cells: advancements, lessons, and applications.
Essayan-Perez S; Zhou B; Nabet AM; Wernig M; Huang YA
Neurobiol Dis; 2019 Oct; 130():104503. PubMed ID: 31202913
[TBL] [Abstract][Full Text] [Related]
9. Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease.
Marei HE; Khan MUA; Hasan A
Cell Mol Biol Lett; 2023 Nov; 28(1):98. PubMed ID: 38031028
[TBL] [Abstract][Full Text] [Related]
10. A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer's Disease and Frontotemporal Dementia Disease Modeling.
Muñoz SS; Engel M; Balez R; Do-Ha D; Cabral-da-Silva MC; Hernández D; Berg T; Fifita JA; Grima N; Yang S; Blair IP; Nicholson G; Cook AL; Hewitt AW; Pébay A; Ooi L
Cells; 2020 Sep; 9(9):. PubMed ID: 32887382
[TBL] [Abstract][Full Text] [Related]
11. Induced Pluripotent Stem Cell (iPSC)-Based Neurodegenerative Disease Models for Phenotype Recapitulation and Drug Screening.
Chang CY; Ting HC; Liu CA; Su HL; Chiou TW; Lin SZ; Harn HJ; Ho TJ
Molecules; 2020 Apr; 25(8):. PubMed ID: 32344649
[TBL] [Abstract][Full Text] [Related]
12. Establishment of KEIOi005-A iPSC line from urine-derived cells (UDCs) of a mild Alzheimer's disease (AD) donor with multiple risk SNPs for sporadic Alzheimer's disease (sAD).
Supakul S; Leventoux N; Tabuchi H; Mimura M; Ito D; Maeda S; Okano H
Stem Cell Res; 2022 Jul; 62():102802. PubMed ID: 35537244
[TBL] [Abstract][Full Text] [Related]
13. Best Practices for Translational Disease Modeling Using Human iPSC-Derived Neurons.
Engle SJ; Blaha L; Kleiman RJ
Neuron; 2018 Nov; 100(4):783-797. PubMed ID: 30465765
[TBL] [Abstract][Full Text] [Related]
14. Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F).
Li L; Kim HJ; Roh JH; Kim M; Koh W; Kim Y; Heo H; Chung J; Nakanishi M; Yoon T; Hong CP; Seo SW; Na DL; Song J
Cell Prolif; 2020 Apr; 53(4):e12798. PubMed ID: 32216003
[TBL] [Abstract][Full Text] [Related]
15. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
16. Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges.
Poon A; Zhang Y; Chandrasekaran A; Phanthong P; Schmid B; Nielsen TT; Freude KK
N Biotechnol; 2017 Oct; 39(Pt B):190-198. PubMed ID: 28579476
[TBL] [Abstract][Full Text] [Related]
17. 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders.
Lee CT; Bendriem RM; Wu WW; Shen RF
J Biomed Sci; 2017 Aug; 24(1):59. PubMed ID: 28822354
[TBL] [Abstract][Full Text] [Related]
18. Establishment of induced pluripotent stem cells from centenarians for neurodegenerative disease research.
Yagi T; Kosakai A; Ito D; Okada Y; Akamatsu W; Nihei Y; Nabetani A; Ishikawa F; Arai Y; Hirose N; Okano H; Suzuki N
PLoS One; 2012; 7(7):e41572. PubMed ID: 22848530
[TBL] [Abstract][Full Text] [Related]
19. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells.
Israel MA; Yuan SH; Bardy C; Reyna SM; Mu Y; Herrera C; Hefferan MP; Van Gorp S; Nazor KL; Boscolo FS; Carson CT; Laurent LC; Marsala M; Gage FH; Remes AM; Koo EH; Goldstein LS
Nature; 2012 Jan; 482(7384):216-20. PubMed ID: 22278060
[TBL] [Abstract][Full Text] [Related]
20. APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer's Disease Phenotypes in Human iPSC-Derived Brain Cell Types.
Lin YT; Seo J; Gao F; Feldman HM; Wen HL; Penney J; Cam HP; Gjoneska E; Raja WK; Cheng J; Rueda R; Kritskiy O; Abdurrob F; Peng Z; Milo B; Yu CJ; Elmsaouri S; Dey D; Ko T; Yankner BA; Tsai LH
Neuron; 2018 Jun; 98(6):1141-1154.e7. PubMed ID: 29861287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
